NEW FILINGS<\/p>\n
Company: FaceBank Group, Inc.
\nSymbol: FUBO
\nDescription: fuboTV is the leading sports-first, live TV streaming platform, offering subscribers access to tens of thousands of live sporting events annually as well as leading news and entertainment content. fuboTV\u2019s platform allows customers to access content through streaming devices, and on SmartTVs, mobile phones, tablets and computers.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): Evercore ISI
\nCo-Manager(s): BMO Capital, Needham, Oppenheimer, Roth Capital, Wedbush
\nFiled: 8-11-20
\nListed Cash Raise: $100m.
\nNote: Their common stock is quoted on the OTCQB Venture Market under the symbol ‘FUBO’. On August 7, 2020, the last reported sale price of their common stock was $10.20 per share.<\/p>\n
Company: XPeng Inc.
\nSymbol: XPEV
\nDescription: They are one of China\u2019s leading smart electric vehicle, or Smart EV, companies.
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): Credit Suisse, J.P. Morgan, BofA Securities
\nFiled: 8-7-20
\nListed Cash Raise: $100m<\/p>\n
TERMS ADDED<\/strong><\/span><\/p>\n Company: Nano-X Imaging Ltd. Company: Inhibrx, Inc. Company: Harmony Biosciences Holdings, Inc.
\nSymbol: NNOX
\nDescription: They are focused on applying their proprietary medical imaging technology to make diagnostic medicine more accessible and affordable across the globe.
\nShares: 5.88 million
\nPrice Range: $16.00-$18.00
\nMarket Cap: $663m-$746m
\nTrade Date: Friday, 8\/21
\nUnderwriter(s): Cantor, Oppenheimer & Co., Berenberg, CIBC Capital Markets
\nTerms Added: 8-14-20<\/p>\n
\nSymbol: INBX
\nDescription: They are a clinical-stage biotechnology company with a pipeline of novel biologic therapeutic candidates, developed using our protein engineering expertise and proprietary single domain antibody, or sdAb, platform.
\nShares: 6 million
\nPrice Range: $16.00-$18.00
\nMarket Cap: $571m-$642m
\nTrade Date: Wednesday, 8\/19
\nUnderwriter(s): Jefferies, Evercore ISI, Credit Suisse
\nCo-Manager: LifeSci Capital
\nTerms Added: 8-12-20
\nNote: Previously Withdrawn in June 2019<\/p>\n
\nSymbol: HRMY
\nDescription: They are a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.
\nShares: 4.65 million
\nPrice Range: $20.00-$23.00
\nMarket Cap: $1.3bn-$1.5bn
\nTrade Date: Wednesday 8\/19
\nUnderwriter(s): Goldman Sachs, Jefferies, Piper Sandler
\nTerms Added: 8-11-20<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":12986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[2058,1536],"tags":[],"class_list":["post-14370","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/14370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=14370"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/14370\/revisions"}],"predecessor-version":[{"id":14373,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/14370\/revisions\/14373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/12986"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=14370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=14370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=14370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}